Imbalance between subpopulations of regulatory T cells in COPD

Thorax

Volumn 68, Issue 12, 2013, Pages 1131-1139

  Hou, Jia ^a,b   Sun, Yongchang ^a   Hao, Yu ^c,d   Zhuo, Jie ^a   Liu, Xiaofang ^a   Bai, Peng ^a   Han, Junyan ^c,d   Zheng, Xiwei ^b   Zeng, Hui ^c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Beijing Key Laboratory of Emerging Infectious Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; FORCED EXPIRATORY VOLUME; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SMOKING; STEADY STATE; SUPPRESSOR CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

BRONCHOSCOPY; COPD AU MECHANISMS; LYMPHOCYTE BIOLOGY;

AGED; ANTIGENS, CD45; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORCED EXPIRATORY VOLUME; HOMEOSTASIS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; T-LYMPHOCYTES, REGULATORY;

EID: 84887501001     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201956     Document Type: Article

References (35)

1. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53 (Pubitemid 38787999)
2. Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immunol 2009;123:986-94
3. Doe C, Bafadhel M, Siddiqui S, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010;138:1140-7
4. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009;30:646-55
5. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:711-17 (Pubitemid 29380694)
6. Saetta M, Turato GB, Casoni GL, et al. Increased proportion of CD8+ T lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. SarcoidosisVasc Lung Dis 2003;20:28-32 (Pubitemid 36559731)
7. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80 (Pubitemid 38901515)
8. Monaco C, Andreakos E, Kiriakidis S, et al. T-cell mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Curr Drug Targets Inflamm Allergy 2004;3:35-42 (Pubitemid 38854888)
9. Curtis JL. Cell-mediated adaptive immune defense of the lungs. Proc Am Thorac Soc 2005;2:412-16 (Pubitemid 43128034)
10. Lan RY, Ansari AA, Lian ZX, et al. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005;4:351-63 (Pubitemid 41080072)
11. Bluestone JA, Tang Q. How do CD4+ CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005;17:638-42 (Pubitemid 41506909)
12. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med 2006;354:1166-76
13. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006;12:178-80 (Pubitemid 43214743)
14. Cederbom L, Hall H, Ivars F. CD4+ CD25+ regulatory T cells down- regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-43 (Pubitemid 30342794)
15. Bonarius HP, Brandsma CA, Kerstjens HA, et al. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax 2011;66:101-7
16. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:156-63
17. Smyth LJ, Starkey C, Vestbo J, et al. CD4-regulatory cells in COPD patients. Chest 2007;132:156-63 (Pubitemid 47068216)
18. Barceló B, Pons J, Ferrer JM, et al. Phenotypic characterisationof T-lymphocytes in COPD: abnormalCD4+ CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008;31:555-62
19. Baraldo S, Saetta M. To reg or not to reg: that is the question in COPD. Eur Respir J 2008;31:486-8
20. Isajevs S, Taivans I, Strazda G, et al. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J 2009;33:61-7
21. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009;30:899-911
22. Simonetta F, Lecuroux C, Girault I, et al. Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection. J Infect Dis 2012;205:1510-19
23. Marwaha AK, Crome SQ, Panagiotopoulos C, et al. Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010;185:3814-18
24. Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009;106:4793-8
25. Ayyoub M, Deknuydt F, Raimbaud I, et al. Human memory FOXP3+Treg secrete IL-17 ex vivo and constitutively express the TH 17 lineage-specific transcription factor ROR?t. Proc Natl Acad Sci U S A 2009;106:8635-40
26. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50 (Pubitemid 46745409)
27. Vanaudenaerde BM, Verleden SE, Vos R, et al. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J RespirCrit Care Med 2011;183:977-86
28. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55 (Pubitemid 47403272)
29. Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;57:405-11 (Pubitemid 34494150)
30. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China. Am J Respir Crit Care Med 2007;176:753-60
31. Kimmig S, Przybylski GK, Schmidt CA, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002;195:789-94 (Pubitemid 34259723)
32. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7 (Pubitemid 41716769)
33. Zhu X, Gadgil AS, Givelber R, et al. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol 2009;182:3270-7
34. Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-6
35. Deeths MJ, Mescher MF. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM. Eur J Immunol 1999;29:45-53. (Pubitemid 29043521)